Ultragenyx Corp - RARE Forvard narx/daromad multiplikatori

Ultragenyx Pharma (RARE) korporativ emblemasi va logotipi

Ultragenyx Pharmaceutical kamyob kasalliklarga qarshi kurashish uchun patent risklarini minimallashtirgan holda gen va hujayra terapiyalarining keng portfelini ishlab chiqmoqda. Biznesning forward P/S ko'rsatkichi 2.20 ga teng bo'lgan holatda, ushbu metrika orqali bozor kutganlarini baholash mumkin. Benuqson obro'ga ega barqaror rahbariyat yangi dori vositalari uchun tasdiqlashlarni tizimli ravishda ta'minlamoqda. mRNA va vektor texnologiyalariga asoslangan innovatsiyalar bemorlarga eng noyob mutatsiyalar uchun terapiyalardan foydalanish imkoniyatini beradi.

RARE ultragenyx.com: Kelajakdagi narxning daromadga nisbati 04.07.2022 - 17.11.2026 oraligʻida

ultragenyx.com (RARE) kompaniyasi koʻrsatkichlari kesimi va tahlili

Kompaniyaning jamlanma tahlili:RARE (Ultragenyx Corp)
Ultragenyx Pharmaceutical tovar namunasi

Ultragenyx Pharmaceutical (RARE) gen terapiyasi uchun yuqori kriogen logistika xarajatlari marjalarga bevosita ta'sir ko'rsatadi, bu esa kutilayotgan P/S koeffitsientini kelajakdagi sotuvlarga bo'lgan bozor ishonchining asosiy ko'rsatkichi qiladi. Ushbu metrika joriy bozor kapitalizatsiyasini prognoz qilingan daromad bilan bog'laydi va investorlarning o'sish potentsiali uchun qo'shimcha to'lov qilishga tayyorligini namoyish etadi; uning o'sishi bozor optimizmini tasdiqlaydi, pasayishi esa aktivlarning haddan tashqari qimmat baholanganligini anglatadi.

Ultragenyx Pharmaceutical (RARE) raqobatchilari

Forvard P/S multiplikatori TEM (Tempus Labs)|Qiagen N.V. - Narxning prognoz qilingan daromadga nisbati|IONS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati repligen.com|RNA: Forvard P/S multiplikatori|CRISPR Therapeutics Inc (CRSP) - Forvard P/S multiplikatori|WGS (GeneDx Holdings) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Beam Therapeutics Inc.|Narxning prognoz qilingan daromadga nisbati Sarepta Therapeutics Inc (SRPT)|Twist Bioscience - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|10x Genomics Inc - Forvard narx/daromad multiplikatori|NTLA (Intellia Therapeutics, Inc.) - Kelajakdagi narxning daromadga nisbati|Stoke Corp - Forvard P/S multiplikatori|BLFS (BioLife) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|wavelifesciences.com (WVE) - Narxning prognoz qilingan daromadga nisbati|MAZE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|SION (Sionna Therapeutics, Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Prime Medicine Corp (PRME)|Forvard P/S multiplikatori TSHA|Forvard P/S multiplikatori uniQure N.V. (QURE)|Narxning prognoz qilingan daromadga nisbati MeiraGTx Holdings plc MGTX|RGNX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Solid Biosciences Inc - Forvard P/S multiplikatori|OCGN - Forvard P/S multiplikatori|PACB: Forvard P/S multiplikatori|BNTC - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Design Therapeutics, Inc.|RCKT: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Korro Bio, Inc. KRRO|EDIT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SLN - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati ProQR Therapeutics (PRQR)|CDXS (Codexis Bio) - Forvard narx/daromad multiplikatori|Sangamo Therapeutics Inc. (SGMO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Nautilus Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Metagenomi Therapeutics MGX|Narxning prognoz qilingan daromadga nisbati Precision BioSciences (DTIL)|GBIO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori BOLD (Boundless Bio, Inc)|XCUR - Forvard narx/daromad multiplikatori|IMNN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Phio Pharmaceuticals Corp|MBIO: Forvard P/S multiplikatori|TransCode (RNAZ) - Forvard P/S multiplikatori|BNGO (Bionano) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Applied DNA Sciences, Inc. APDN|Forvard P/S multiplikatori BLUE|ImmunoPrecise Antibodies Ltd - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omega Therapeutics OMGA|OMIC: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGLS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON)|Narxning prognoz qilingan daromadga nisbati Unity Biotechnology, Inc.